We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Alliance to Improve Radiation Therapy

By HospiMedica staff writers
Posted on 12 Oct 2004
Calypso Medical (Seattle, WA, USA) has announced a strategic collaboration with Philips Medical Systems (Best, The Netherlands) that will enable the development of products with the potential to deliver both adaptive and image-guided radiation therapy (IGRT). More...
The collaboration was announced at the annual meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO) in Atlanta (GA, USA) in October 2004.

Philips expects to provide enhancements to its treatment planning systems with target localization from the Calypso 4D Localization system as a result of this collaboration. The Localization system was designed to provide an objective and continuous method to setup treatment and monitor the patient during radiation delivery without adding ionizing radiation.

"Working together with the leaders in the field of radiation therapy, we can provide the ‘missing link' to advance radiation treatment options,” said Eric R. Meier, Calypso Medical's president and CEO. "Today's highly conformal radiation therapy treatment options rely on knowing the exact location of the target moment to moment. Establishing a relationship with Philips marks a commitment to advance planning and delivery techniques such as adaptive radiation therapy.”

Using its proprietary AC electromagnetic technology, the Calypso system has excellent capability to pinpoint the target continuously throughout the treatment process, without adding ionizing radiation. The open-system architecture design enables the integration of localization and tracking information through the care pathway from simulation through treatment delivery.

"Calypso Medical's technology, in conjunction with the Pinnacle3 and AcQSim treatment planning and simulation solutions from Philips, has the potential to deliver on the promise of adaptive and image-guided radiation therapy. The end result is expected to be among the most precise treatments available to patients,” remarked Keith Tipton, general manager, radiation oncology, Philips Medical Systems.


Related Links:
Calypso Medical
Philips Medical Systems

Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Enteral Feeding Pump
SENTINELplus
Imaging Table
Stille imagiQ2
Morcellator
TCM 3000 BL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.